Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 26, 2022Proceedings of the National Academy of SciencesOpen Access

Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo

View Full Paper
Ask AI
Bookmark
Share

Authors

CBCasper de BoerZAZachary ArmstrongVLVincent A. J. Lit

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Boer et al. (2022) studied this question.

synapsesocial.com/papers/6a7b91c8b6db831c5f75d080https://doi.org/10.1073/pnas.2203167119
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics2008 · 6,117 citations
  2. 2Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function2008 · 150 citations
  3. 3Design, synthesis, and evaluation of heparan sulfate mimicking glycopolymers for inhibiting heparanase activity2017 · 52 citations
  4. 4Heparin and heparan sulfate: structure and function2002 · 871 citations